Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04

J Nucl Cardiol. 2022 Oct;29(5):2254-2261. doi: 10.1007/s12350-021-02603-z. Epub 2021 Apr 15.

Abstract

Our previous study has demonstrated the feasibility of noninvasive imaging of fibroblast activation protein (FAP)-expression after myocardial infarction (MI) in MI-territory in a rat model with 68Ga-FAPI-04-PET. In the current extended clinical case, we sought to delineate cardiac uptake of 68Ga-FAPI-04 in a patient after MI with clinical indication for the evidence of fibroblast activation. Carcinoma patients without cardiac disease underwent 68Ga-FAPI-04-PET/CT as control. The patient with one-vessel disease underwent dynamic 68Ga-FAPI-04-cardiac-PET/CMR for 60 minutes. Correlation of cardiac 68Ga-FAPI-04 uptake with clinical findings, ECG, echocardiography, coronary-arteriography and enhanced cardiac-MRI with T1 MOLLI and ECV mapping were performed. No uptake was found in normal myocardium and in mature scar. A focal intense 68Ga-FAPI-04 uptake with continuous wash-out in the infarct territory of coronary occlusion correlating with T1 and ECV mapping was observed. The uptake of 68Ga-FAPI-04 extends beyond the actual infarcted area and overestimates the infarct size as confirmed by follow-up CMR.

Keywords: CAD; PET; diagnostic and prognostic application; hybrid imaging; molecular imaging agents; myocardial ischemia and infarction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Gallium Radioisotopes*
  • Membrane Proteins / metabolism
  • Myocardial Infarction* / diagnostic imaging
  • Myocardial Infarction* / pathology
  • Positron Emission Tomography Computed Tomography
  • Quinolines
  • Rats

Substances

  • 68Ga-FAPI
  • Gallium Radioisotopes
  • Membrane Proteins
  • Quinolines